Press Release




Perrigo Voluntarily Recalls Albuterol Sulfate Inhalation Aerosol

A voluntary U.S. nationwide recall of albuterol sulfate inhalation aerosol to the retail level after previously halting production and distribution.

Genome Editing and Cellular Therapies Show Promise for Treating Blood Disorders, Cancers

Three studies report promising results in the use of cutting-edge genome editing and cellular therapies for hard-to-treat blood disorders and cancers.

Sheba Medical Center Selects Two Digital Startups for Integration into Newly Expanded Rehabilitation Ward

Israeli Startups Cognishine and Kemtai Will Begin a Pilot Program at Sheba to Provide Physical, Cognitive and Emotional Rehab Support for Injured Soldiers  ARC Innovation...

The Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program Announces First Group of Physicians to be Trained

52 physicians from across the U.S. selected for the inaugural cohort of the five-year, $100 million initiative Initiative is part of the BMS Foundation commitment...